Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

166
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulator of G protein signaling 10: a critical regulator of chronic systemic inflammation in parkinson's disease.

Journal of neuroinflammation·2026
Same author

RGS10 differentially modulates NFKB subunit transcription and inflammatory cytokine profiles in peritoneal macrophages.

bioRxiv : the preprint server for biology·2026
Same author

C1q-dependent clearance of alpha-synuclein allows macrophages to transiently limit enteric synucleinopathy in male mice.

Nature communications·2026
Same author

Spatial single-cell multiomics reveals peripheral immune dysfunction in Parkinson's and inflammatory bowel disease.

NPJ Parkinson's disease·2026
Same author

Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders.

Nature aging·2025
Same author

Parkinson's-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa.

Movement disorders : official journal of the Movement Disorder Society·2025

Related Experiment Video

Updated: May 20, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K

Immune cell metabolic dysfunction in Parkinson's disease.

Julian R Mark1,2,3, Malú Gámez Tansey4,5,6

  • 1Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.

Molecular Neurodegeneration
|March 25, 2025
PubMed
Summary
This summary is machine-generated.

Cellular metabolic dysfunction drives Parkinson's disease (PD) by promoting inflammation in immune cells, leading to neurodegeneration. Targeting these immunometabolic pathways may offer new therapeutic strategies for PD.

More Related Videos

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry
07:18

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry

Published on: May 24, 2024

918
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.3K

Related Experiment Videos

Last Updated: May 20, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry
07:18

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry

Published on: May 24, 2024

918
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.3K

Area of Science:

  • Neuroscience
  • Immunology
  • Metabolic Medicine

Background:

  • Parkinson's disease (PD) involves dopaminergic neuron degeneration.
  • Cellular metabolic dysfunction is increasingly implicated in PD pathogenesis.
  • Metabolic defects are observed in both neurons and immune cells in PD.

Purpose of the Study:

  • To review the overlap between neuronal and immune cell metabolic deficits in PD.
  • To highlight the role of immunometabolic dysfunction in PD-related inflammation.
  • To identify potential biomarkers and therapeutic targets for PD.

Main Methods:

  • Literature review of studies on cellular metabolism in PD.
  • Analysis of emerging findings in neuroinflammation and immunometabolism.
  • Synthesis of data on metabolic dysfunction in central and peripheral immune cells.

Main Results:

  • Metabolic deficits in neurons and immune cells contribute to PD.
  • Synergistic effects in immune cells promote aberrant inflammation.
  • Inflammation creates a hostile environment for vulnerable neurons.

Conclusions:

  • Immunometabolic dysfunction is a key factor in PD.
  • Understanding these pathways can lead to novel biomarkers.
  • Development of immunomodulatory strategies may delay PD progression.